Tag: next generation mRNA-based vaccines
GSK, CureVac team up to develop and manufacture vaccine against COVID-19 mutants
UK-based GlaxoSmithKline announced today that it has partnered with German pharmaceutical company CureVac to jointly develop next-generation mRNA vaccines for emerging COVID-19 variants.
The €150m...
Featured Article
Driving the future of smart energy: GridBeyond and ABB unveil new white paper on battery storage innovation
As industries adopt cleaner, more intelligent energy solutions, the ability to manage, store, and trade energy efficiently is increasingly vital to sustaining a competitive edge.
